<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02284711</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL14_0166</org_study_id>
    <nct_id>NCT02284711</nct_id>
  </id_info>
  <brief_title>Impact of Salpingectomy on Ovarian Reserve</brief_title>
  <acronym>SALPOVA</acronym>
  <official_title>Impact of Salpingectomy on Ovarian Reserve, With Comparison Between Two Coagulation Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epithelial cancer of the ovaries is the most severe form of gynecologic cancer; a significant
      proportion of ovarian cancers originate from the Fallopian tube. Guidelines therefore now
      recommend systematically associating prophylactic salpingectomy to benign hysterectomy. The
      principal objective of the present study is to assess the impact of salpingectomy on ovarian
      reserve by anti-Müllerian hormone (AMH) assay and calculating the Doppler index of vascular
      resistance in the ovarian vessels. The secondary objective is to compare ovarian reserve
      results between two coagulation techniques used in salpingectomy: bipolar electric energy
      versus ultrasound.

      The study design is single-center, prospective, before-and-after, with open randomization
      between two groups defined by coagulation technique.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 9, 2015</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AMH level</measure>
    <time_frame>3 months post-surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AMH level</measure>
    <time_frame>1 month post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>index of vascular resistance in the ovarian vessels</measure>
    <time_frame>1 and 3 months post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>menopausal quality of life score</measure>
    <time_frame>1 and 3 months post-surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Laparoscopic Salpingectomy</condition>
  <arm_group>
    <arm_group_label>Bipolar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coagulation during salpingectomy using conventional bipolar electric energy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bipolar electric energy</intervention_name>
    <description>Coagulation during salpingectomy using conventional bipolar electric energy</description>
    <arm_group_label>Bipolar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ultrasound energy</intervention_name>
    <description>Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy</description>
    <arm_group_label>Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female subjects aged 18

          -  Scheduled surgery: bilateral laparoscopic salpingectomy associated to hysterectomy for
             benign indication

        Exclusion Criteria:

          -  Interview revealing disorder entailing unacceptable risk of postoperative
             complications: coagulation disorder, immune system disorder, evolutive disease, etc.

          -  Pregnancy, ongoing or planned during the study period

          -  History of bilateral salpingectomy

          -  Salpingectomy associated with pelvic cancer

          -  Oral hormonal contraception during the study period

          -  Menopause

          -  Inability to understand information provided

          -  Not covered by a national health insurance scheme, prisoner or under administrative
             supervision.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gery LAMBLIN, Dr</last_name>
    <phone>4 72 35 58 71</phone>
    <phone_ext>+33</phone_ext>
    <email>gery.lamblin@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - HFME</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gery LAMBLIN</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2014</study_first_submitted>
  <study_first_submitted_qc>November 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2014</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>salpingectomy, ovarian reserve, coagulation technique</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

